Revlimid and Clostridium difficile sepsis - a phase IV clinical study of FDA data

Summary:

Clostridium difficile sepsis is reported as a side effect among people who take Revlimid (lenalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Flagyl, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Clostridium difficile sepsis when taking Revlimid. It is created by eHealthMe based on reports of 377,717 people who have side effects when taking Revlimid from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Clostridium difficile sepsis?

Clostridium difficile sepsis (infection(pus formation) of colon by clostridium difficile bacteria) is found to be associated with 16 drugs and 146 conditions by eHealthMe. Check the latest studies of Clostridium difficile sepsis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

377,717 people reported to have side effects when taking Revlimid.
Among them, 12 people (0.0%) have Clostridium difficile sepsis.

Could Revlimid cause Clostridium difficile sepsis?

Among these 12 people:

How long have people been on Revlimid when they have Clostridium difficile sepsis? *

What is the gender of people who have Clostridium difficile sepsis when taking Revlimid? *

female: 25 %
male: 75 %

What is the age of people who have Clostridium difficile sepsis when taking Revlimid? *

What are other drugs people take besides Revlimid? *

What are other side effects people have besides Clostridium difficile sepsis? *

Pneumonia: 3 people, 25.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 25.00%
Acute Kidney Failure: 2 people, 16.67%
Hypotension (abnormally low blood pressure): 2 people, 16.67%
Lymphoma (cancer that begins in immune system cells): 2 people, 16.67%
White Blood Cell Count Decreased: 1 person, 8.33%
Blood Potassium Decreased: 1 person, 8.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 8.33%
Collapse Of Lung (functional breakdown of lung): 1 person, 8.33%
Clavicle Fracture: 1 person, 8.33%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 5 people, 41.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 41.67%
High Blood Pressure: 3 people, 25.00%
Pain: 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 2 people, 16.67%
Insomnia (sleeplessness): 2 people, 16.67%
Infection: 2 people, 16.67%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 16.67%
Fever: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Clostridium difficile sepsis?

- Check whether Clostridium difficile sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revlimid:

Revlimid (378,026 reports)

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Clostridium difficile sepsis:

Clostridium difficile sepsis (16 drugs)

Browse all the conditions that are associated with Clostridium difficile sepsis:

Clostridium difficile sepsis (146 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.